| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/08/2005 | US6852736 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 02/08/2005 | US6852734 Indole wherein A is an oxygen atom or a nitrogen atom which nitrogen atom is optionally substituted with an alkyl group, and (i) R1 and R2 each stand for a hydrogen atom or an alkyl group, independently, or (ii) R1 and R2 as taken together form |
| 02/08/2005 | US6852733 Sodium-hydrogen exchanger type 1 inhibitor |
| 02/08/2005 | US6852732 A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula (I): has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. (Corticotropin releasing factor |
| 02/08/2005 | US6852730 Substituted fused pyrazolecarboxylic acid arylamides and related compounds |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 02/08/2005 | US6852673 Herbicidal pyridine compounds |
| 02/08/2005 | CA2322900C 2-(hetero)aryl-substituted purin-6-ones as phosphodiesterase inhibitors |
| 02/08/2005 | CA2130754C Amine derivatives of oxo- and hydroxy-substituted hydrocarbons |
| 02/08/2005 | CA2112081C Imidazole compounds, their preparation and use |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | WO2005010001A1 Nicotinamide derivatives useful as pdea4 inhibitors |
| 02/03/2005 | WO2005009997A1 3,5 disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 02/03/2005 | WO2005009991A1 Process for producing 1,2,4-triazole compound and intermediate therefor |
| 02/03/2005 | WO2005009989A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009988A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 02/03/2005 | WO2005009987A1 Piperidine compounds and pharmaceutical compositions containing them |
| 02/03/2005 | WO2005009980A1 Substituted pyridin-2-ylamine analogues |
| 02/03/2005 | WO2005009978A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 02/03/2005 | WO2005009977A1 Substituted pyrimidin-4-ylamina analogues as vanilloid receptor ligands |
| 02/03/2005 | WO2005009974A1 Imidazole compounds and uses thereof |
| 02/03/2005 | WO2005009973A1 5-membered heterocycle-based p38 kinase inhibitors |
| 02/03/2005 | WO2005009967A2 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/03/2005 | WO2005009966A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009965A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009964A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009959A1 Piperidine derivatives as ccr5 receptor modulators |
| 02/03/2005 | WO2005009958A1 Ppar active compounds |
| 02/03/2005 | WO2005009957A1 Tyrosine kinase inhibitors |
| 02/03/2005 | WO2005009435A1 Aminopyrazole compounds and use as chk1 inhibitors |
| 02/03/2005 | WO2005009373A2 Tyrosine kinase inhibitors |
| 02/03/2005 | WO2004106307A3 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 02/03/2005 | WO2004075840A3 Selective non-steroidal glucocorticoid receptor modulators |
| 02/03/2005 | WO2004072102A3 Benzene acetamide compounds useful as serine protease inhibitors |
| 02/03/2005 | WO2004054581A3 Cyclohexyl compounds as ccr5 antagonists |
| 02/03/2005 | WO2003106450A8 Phenylaminopyrimidines and their use as rho-kinase inhibitors |
| 02/03/2005 | US20050027129 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/03/2005 | US20050027121 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases |
| 02/03/2005 | US20050027007 Allylamides useful in the treatment of alzheimer's disease |
| 02/03/2005 | US20050026991 mono-N-substituted amide monohydroxyamide derivatives, e.g., 1-Benzyl-3-(3,4-dichloro-benzyloxy)-1H-pyrrole-2,4-dicarboxylic acid 2-[(1-benzyl-piperidin-4-yl)-amide]4-hydroxyamide, that modulate levels of gene expression in cellular systems, including cancer cells |
| 02/03/2005 | US20050026990 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders |
| 02/03/2005 | US20050026989 treatment or prophylaxis of cardiovascular disease, metabolic disease, cancerous disease, or fibrotic disease; arrhythmias, life-threatening cardiac ventricular fibrillation, myocardial infarction, angina pectoris; ischemic states of the heart, diabetes |
| 02/03/2005 | US20050026988 Cyclopenta'b! indole derivatives as spla inhibitors |
| 02/03/2005 | US20050026985 Such as N-{5-[1-(4-tert-butylphenyl)-3-pyridin-2-yl-1H-pyrazol-5-yl]pentanoyl}tyrosinamide; useful for the treatment of mammalian infertility |
| 02/03/2005 | US20050026983 Imidazole compounds and uses thereof |
| 02/03/2005 | US20050026976 Isoindolinone kinase inhibitors |
| 02/03/2005 | US20050026975 Such as ethyl 4-chloroacetamido-N-(3,4-dichlorobenzyl)indole-2-carboxylate use in the treatment of disease mediated by monocyte chemoattractant protein-1 |
| 02/03/2005 | US20050026968 Heterocyclic amides with anti-tuberculosis activity |
| 02/03/2005 | US20050026964 4-(2-Fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydro-3-pyridinecarboxamide for treating cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, rheumatoid arthritis, heart failure, chronic pain, neuropathic pain, or osteoarthritis |
| 02/03/2005 | US20050026963 Pyrazole substituted directly, or by a bridge, with a heteroaryl group containing N adjacent to the point of connection of the heteroaryl useful in the treatment of psychiatric and mood disorders such as, schizophrenia, anxiety, depression, bipolar disorder, circadian rhythm and sleep disorders |
| 02/03/2005 | US20050026960 3-((mono- or di-fluoro-benzimidazol-2-yl))-5-(4-methyl-5-(ethylaminomethyl)pyrid-3-yl)indazole; inhibitors of cyclin dependent kinases(CDK) for use treating cancer and other proliferative disorders such as retinopathy, rheumatoid arthritis |
| 02/03/2005 | US20050026956 Carbinols for the treatment of neuropathic dysfunction |
| 02/03/2005 | US20050026955 Radiolabeled piperidine derivatives; chelate compounds; complexes with technetium |
| 02/03/2005 | US20050026954 Muscarinic receptor antagonists; overactive bladder, irritable bowel syndrome, chronic obstructive pulmonary disease, and asthma |
| 02/03/2005 | US20050026952 Nicotinamide derivatives useful as PDE4 inhibitors |
| 02/03/2005 | US20050026942 Chemokine receptor binding heterocyclic compounds |
| 02/03/2005 | US20050026940 Processes for the preparation of substituted bicyclic derivatives |
| 02/03/2005 | US20050026929 2-Phenyl-4-(piperidin-1-ylcarbonyl)-oxazole derivatives; capsase activators; cancer, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, or psoriasis |
| 02/03/2005 | US20050026928 Chemical compounds |
| 02/03/2005 | US20050026927 Pyrazole derivatives as psychopharmaceuticals |
| 02/03/2005 | US20050026923 For therapy of viral diseases |
| 02/03/2005 | US20050026918 Novel pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them |
| 02/03/2005 | US20050026917 Tricyclic indanyls as integrin inhibitors |
| 02/03/2005 | US20050026916 Heterocyclic compounds as P2X7 ion channel blockers |
| 02/03/2005 | US20050026915 As melanin concentrating hormone (MCH)receptor antagonists, for prevention or treatment of obesity or eating disorders; (2E)-3-(4-chlorophenyl)-N-[2-(dimethylamino)quinolin-6-yl]prop-2-enamide |
| 02/03/2005 | US20050026914 Pyrimidine or pyridine carbamate compounds as for example 1,1-dimethylethyl 4-(4-((4-((((2,6-dimethylphenyl)oxy)carbonyl)(4-(methyloxy)phenyl)amino)-2-pyrimidinyl)amino)phenyl)-1-piperazinecarboxylate; for the treatment of protein tyrosine kinase-associated disorders |
| 02/03/2005 | US20050026911 Benzotriazapinone salts and methods for using same |
| 02/03/2005 | US20050026903 Pyrazole compound; gastrointestinal disorders; central nervous system disorders |
| 02/03/2005 | US20050026810 Treatment of male sexual dysfunction |
| 02/03/2005 | US20050025774 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; for preventing, treating or delaying AIDS |
| 02/03/2005 | US20050025702 radiotherapeutic or chemotherapeutic agents comprising metalloenzyme inhibitors and chelation compounds capable of conjugating to cytotoxic radioisotopes; anticarcinogenic agents |
| 02/03/2005 | CA2744317A1 Substituted tetracycline compounds |
| 02/03/2005 | CA2534262A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | CA2533681A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | CA2533663A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | CA2533662A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | CA2533626A1 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/03/2005 | CA2533603A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | CA2533397A1 Substituted pyridin-2-ylamine analogues |
| 02/03/2005 | CA2532980A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 02/03/2005 | CA2532908A1 3,5 disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 02/03/2005 | CA2532443A1 Tyrosine kinase inhibitors |
| 02/03/2005 | CA2532403A1 Ppar active compounds |
| 02/03/2005 | CA2532400A1 Tyrosine kinase inhibitors |
| 02/03/2005 | CA2532231A1 Aminopyrazole compounds and use as chk1 inhibitors |
| 02/03/2005 | CA2531912A1 Process for producing 1,2,4-triazole compound and intermediate therefor |
| 02/03/2005 | CA2531490A1 Substituted pyrimidin-4-ylamina analogues as vanilloid receptor ligands |
| 02/03/2005 | CA2530352A1 Quinolone derivative or salt thereof |
| 02/02/2005 | EP1502916A1 Piperidine derivatives having ccr3 antagonism |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501825A2 Substituted imidazolylmethyl pyridine and pyrazine derivatives: gaba a receptor ligands |
| 02/02/2005 | EP1501824A1 A method for the purification of lansoprazole |
| 02/02/2005 | EP1501823A1 New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds |
| 02/02/2005 | EP1501822A1 Phthalazinone derivatives |
| 02/02/2005 | EP1501809A1 Triazole derivatives as tachykinin receptor antagonists |
| 02/02/2005 | EP1501808A1 Tachykinin receptor antagonists |